Simon C. Robson

Active 1994–2025

Also published as
Simon C Robson
199
Papers
31,292
Citations
102
h-index
194
i10-index

Citations

Citations per year for Simon C. Robson1986: 1 citations1995: 1 citations1996: 16 citations1997: 26 citations1998: 65 citations1999: 68 citations2000: 81 citations2001: 78 citations2002: 84 citations2003: 111 citations2004: 135 citations2005: 141 citations2006: 212 citations2007: 267 citations2008: 296 citations2009: 234 citations2010: 224 citations2011: 358 citations2012: 332 citations2013: 345 citations2014: 320 citations2015: 292 citations2016: 304 citations2017: 355 citations2018: 317 citations2019: 991 citations2020: 1,354 citations2021: 1,365 citations2022: 1,062 citations2023: 807 citations2024: 1,158 citations2025: 655 citations2026: 17 citations1987–1994: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,342 citing papers, 28.3% of this breakdownChina: 1,776 citing papers, 15% of this breakdownGermany: 810 citing papers, 6.9% of this breakdownUnited Kingdom: 642 citing papers, 5.4% of this breakdownItaly: 541 citing papers, 4.6% of this breakdownCanada: 414 citing papers, 3.5% of this breakdownFrance: 372 citing papers, 3.1% of this breakdownJapan: 298 citing papers, 2.5% of this breakdownAustralia: 278 citing papers, 2.4% of this breakdownSpain: 213 citing papers, 1.8% of this breakdownBrazil: 210 citing papers, 1.8% of this breakdownSwitzerland: 205 citing papers, 1.7% of this breakdown
0%28.3%Other 23%

Fields

  • Biochemistry, Genetics and Molecular Biology37.7%
  • Medicine33.9%
  • Immunology and Microbiology16.8%
  • Neuroscience8.2%
  • Nursing0.9%
  • Engineering0.8%
  • Other1.7%

Topics

  • Adenosine and Purinergic Signaling7%
  • Immune Cell Function and Interaction5.7%
  • Immune cells in cancer3.4%
  • T-cell and B-cell Immunology2.8%
  • Neuroinflammation and Neurodegeneration Mechanisms2.8%
  • Cancer Immunotherapy and Biomarkers2.7%
  • Other75.6%

Coauthors

All papers

Open in search
  1. Negative feedback control of neuronal activity by microglia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2020 cited by 1,023

  2. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

    Authors: , , , , , , , , , , , , - The Journal of Experimental Medicine 2007 cited by 2,384

  3. The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets

    Authors: , , , - Immunological Reviews 2017 cited by 895

  4. Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity

    Authors: , , , , , , , , , , , , - Nature Immunology 2022 cited by 250

  5. Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Neuroscience 2019 cited by 526

  6. The metabolite BH4 controls T cell proliferation in autoimmunity and cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Simon C. Robson, Ari Waisman, Nick Andrews, Michael Costigan, Keith M. Channon, Günter Weiß, Andrey V. Kozlov, Mark Tebbe, Kai Johnsson, Clifford J. Woolf, Josef Penninger - Nature 2018 cited by 287

  7. CD39 Expression Identifies Terminally Exhausted CD8+ T Cells

    Authors: , , , , , , , , , , , , , , , , - PLoS Pathogens 2015 cited by 390

  8. Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2019 cited by 268

  9. Multiomics of Tissue Extracellular Vesicles Identifies Unique Modulators of Atherosclerosis and Calcific Aortic Valve Stenosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Circulation 2023 cited by 85

  10. Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α

    Authors: , , , , , , , , , , , , , , - Nature Medicine 2015 cited by 446

  11. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury

    Authors: , , , , , , , , , , , , , - Journal of Hepatology 2017 cited by 189

  12. Purinergic Signaling during Inflammation

    Authors: , , - New England Journal of Medicine 2012 cited by 698

  13. CD150high Bone Marrow Tregs Maintain Hematopoietic Stem Cell Quiescence and Immune Privilege via Adenosine

    Authors: , , , , , , , , - Cell stem cell 2018 cited by 240

  14. CD73 Inhibits cGAS–STING and Cooperates with CD39 to Promote Pancreatic Cancer

    Authors: , , , , , , , , , , , , , , , , , , , - Cancer Immunology Research 2022 cited by 73

  15. Regulation of the T Cell Response by CD39

    Authors: , , - Trends in Immunology 2016 cited by 201

  16. Enteric Glia Modulate Macrophage Phenotype and Visceral Sensitivity following Inflammation

    Authors: , , , , , , , , , , , - Cell Reports 2020 cited by 158

  17. CD69 expression on regulatory T cells protects from immune damage after myocardial infarction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2022 cited by 49

  18. The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance

    Authors: , , - Purinergic Signalling 2006 cited by 927

  19. Conversion of extracellular ATP into adenosine: a master switch in renal health and disease

    Authors: , , - Nature Reviews Nephrology 2020 cited by 144

  20. IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39

    Authors: , , , , , , , , , , , , - Nature Immunology 2013 cited by 325

  21. Altered aryl-hydrocarbon-receptor signalling affects regulatory and effector cell immunity in autoimmune hepatitis

    Authors: , , , , , , , , , , , - Journal of Hepatology 2020 cited by 65

  22. Heart transplantation in baboons using α1,3-galactosyltransferase gene-knockout pigs as donors: initial experience

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2004 cited by 695

  23. Increased Intestinal Microbial Diversity Following Fecal Microbiota Transplant for Active Crohnʼs Disease

    Authors: , , , , , , , , , - Inflammatory Bowel Diseases 2016 cited by 231

  24. Stat3 and Gfi-1 Transcription Factors Control Th17 Cell Immunosuppressive Activity via the Regulation of Ectonucleotidase Expression

    Authors: , , , , , , , , , , , , , , , , , - Immunity 2012 cited by 324